Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,951 | 491 | 59.3% |
| Consulting Fee | $5,680 | 3 | 33.9% |
| Travel and Lodging | $683.56 | 2 | 4.1% |
| Education | $463.60 | 6 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Dermavant Sciences, Inc. | $4,563 | 35 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $2,286 | 39 | $0 (2024) |
| Janssen Biotech, Inc. | $1,639 | 71 | $0 (2024) |
| Galderma Laboratories, L.P. | $1,182 | 59 | $0 (2024) |
| Merz North America, Inc. | $1,140 | 9 | $0 (2022) |
| Medimetriks Pharmaceuticals, Inc. | $1,000 | 1 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $891.54 | 88 | $0 (2023) |
| ABBVIE INC. | $652.10 | 29 | $0 (2024) |
| Sun Pharmaceutical Industries Inc. | $632.08 | 36 | $0 (2023) |
| Lilly USA, LLC | $534.86 | 27 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,407 | 75 | Dermavant Sciences, Inc. ($4,025) |
| 2023 | $1,831 | 94 | Janssen Biotech, Inc. ($624.00) |
| 2022 | $2,673 | 81 | Merz North America, Inc. ($1,122) |
| 2021 | $1,905 | 88 | Ortho Dermatologics, a division of Bausch Health US, LLC ($422.60) |
| 2020 | $2,377 | 72 | Ortho Dermatologics, a division of Bausch Health US, LLC ($1,464) |
| 2019 | $787.76 | 43 | Galderma Laboratories, L.P. ($254.29) |
| 2018 | $510.96 | 22 | Galderma Laboratories, L.P. ($448.38) |
| 2017 | $1,287 | 27 | Medimetriks Pharmaceuticals, Inc. ($1,000) |
All Payment Transactions
502 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $28.14 | General |
| Category: Immunology | ||||||
| 11/25/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $26.59 | General |
| Category: Inflammation & Immunology | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: Immunology | ||||||
| 11/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $27.25 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.00 | General |
| Category: Immunology | ||||||
| 10/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: Inflammation | ||||||
| 10/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: Immunology | ||||||
| 10/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $1.53 | General |
| Category: Immunology | ||||||
| 10/17/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $12.68 | General |
| 10/17/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $4.90 | General |
| 10/15/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: Immunology | ||||||
| 10/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: IMMUNOLOGY | ||||||
| 10/03/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $13.65 | General |
| 09/30/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $25.23 | General |
| Category: Inflammation | ||||||
| 09/24/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: Immunology | ||||||
| 09/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $8.11 | General |
| Category: Immunology | ||||||
| 09/16/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: Dermatology | ||||||
| 09/11/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $30.36 | General |
| Category: DERMATOLOGY | ||||||
| 09/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $27.40 | General |
| Category: IMMUNOLOGY | ||||||
| 08/27/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: Immunology | ||||||
| 08/26/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: IMMUNOLOGY | ||||||
| 08/22/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: Inflammation | ||||||
| 08/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.68 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 3,404 | 5,765 | $1.2M | $393,886 |
| 2022 | 25 | 3,206 | 5,110 | $1.1M | $361,048 |
| 2021 | 19 | 2,440 | 3,766 | $870,625 | $329,672 |
| 2020 | 21 | 1,940 | 2,923 | $666,235 | $227,660 |
All Medicare Procedures & Services
89 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,022 | 1,698 | $362,007 | $119,023 | 32.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 534 | 632 | $156,779 | $51,494 | 32.8% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 74 | 80 | $131,984 | $48,560 | 36.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 376 | 528 | $85,865 | $25,426 | 29.6% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 45 | 60 | $60,210 | $22,968 | 38.1% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 80 | 88 | $65,447 | $20,181 | 30.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 227 | 227 | $61,038 | $19,376 | 31.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 168 | 208 | $57,673 | $18,957 | 32.9% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 21 | 21 | $32,582 | $12,316 | 37.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 188 | 246 | $33,111 | $10,524 | 31.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 238 | 1,244 | $19,870 | $7,388 | 37.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 115 | 134 | $16,413 | $6,137 | 37.4% |
| 10040 | Acne surgery | Office | 2023 | 48 | 55 | $15,594 | $5,206 | 33.4% |
| 11901 | Injection into skin growth, more than 7 growths | Office | 2023 | 19 | 88 | $14,829 | $4,733 | 31.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 38 | 43 | $12,919 | $4,102 | 31.8% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 30 | 34 | $20,266 | $3,861 | 19.1% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 19 | 20 | $15,165 | $3,033 | 20.0% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 17 | 17 | $13,173 | $2,513 | 19.1% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 35 | 62 | $8,569 | $2,510 | 29.3% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 18 | 20 | $6,082 | $2,209 | 36.3% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 12 | 15 | $4,598 | $1,398 | 30.4% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 18 | 18 | $3,109 | $965.07 | 31.0% |
| 69100 | Biopsy of ear | Office | 2023 | 11 | 12 | $2,833 | $853.10 | 30.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 51 | 215 | $468.59 | $151.71 | 32.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 1,029 | 1,637 | $351,561 | $117,807 | 33.5% |
About Dr. David Avram, MD
Dr. David Avram, MD is a Specialist healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1972598100.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Avram, MD has received a total of $16,778 in payments from pharmaceutical and medical device companies, with $5,407 received in 2024. These payments were reported across 502 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($9,951).
As a Medicare-enrolled provider, Avram has provided services to 10,990 Medicare beneficiaries, totaling 17,564 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 89 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Location Brooklyn, NY
- Active Since 09/14/2005
- Last Updated 11/10/2008
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1972598100
Products in Payments
- VTAMA (Drug) $4,563
- DUOBRII (Drug) $1,732
- TREMFYA (Drug) $1,552
- Xeomin (Biological) $1,122
- Neo-Synalar Cream (Drug) $1,000
- COSENTYX (Biological) $684.43
- EPIDUO FORTE (Drug) $621.70
- SKYRIZI (Biological) $518.29
- TALTZ (Drug) $511.36
- EUCRISA (Drug) $382.49
- Otezla (Drug) $274.64
- ARAZLO (Drug) $245.12
- ILUMYA (Biological) $195.86
- SOOLANTRA (Drug) $185.31
- Bimzelx (Biological) $175.23
- DUPIXENT (Biological) $174.95
- Absorica LD (Drug) $165.76
- COSENTYX (Drug) $140.37
- Cimzia (Drug) $128.67
- JUBLIA (Drug) $122.04
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Brooklyn
Idan Sharon, M.d, M.D
Specialist — Payments: $2.3M
Dr. Sean Studer, M.d, M.D
Specialist — Payments: $411,591
Dr. Michael Lewis, M.d, M.D
Specialist — Payments: $68,268
Dr. Marc Avram, Md, MD
Specialist — Payments: $48,018
Michael Amoashiy, Md, MD
Specialist — Payments: $41,408
Dr. Madhavi Reddy, M.d, M.D
Specialist — Payments: $40,649